{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T19:30:04Z","timestamp":1775071804112,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1993,5,1]],"date-time":"1993-05-01T00:00:00Z","timestamp":736214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[1993,5]]},"DOI":"10.1007\/bf01525435","type":"journal-article","created":{"date-parts":[[2005,4,19]],"date-time":"2005-04-19T02:40:48Z","timestamp":1113878448000},"page":"195-202","source":"Crossref","is-referenced-by-count":32,"title":["Preclinical investigation of the antitumour effects of anti-CD19-idarubicin immunoconjugates"],"prefix":"10.1007","volume":"37","author":[{"given":"A. J.","family":"Rowland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. A.","family":"Pietersz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. F. C.","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"5225","volume":"50","author":"SM Andrew","year":"1990","unstructured":"Andrew SM, Teh JG, Johnstone RW, Russell SM, Whitehead RH, McKenzie IFC, Pietersz GA (1990) Tumor localisation by combinations of monoclonal antibodies in a new human colon carcinoma cell line (LIM 1899). Cancer Res 50: 5225","journal-title":"Cancer Res"},{"key":"CR2","first-page":"947","volume":"47","author":"DC Blakey","year":"1987","unstructured":"Blakey DC, Watson GJ, Knowles PP, Thorpe PE (1987) Effect of chemical deglycosylation of ricin A chain on the in vivo fate and cytotoxic activity of an immunotoxin composed of ricin A chain and anti-Thy 1.1. antibody. Cancer Res 47: 947","journal-title":"Cancer Res"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00172075","volume":"1","author":"V Bonfante","year":"1983","unstructured":"Bonfante V, Ferrari L, Villani F, Bonadonna G (1983) Phase I study of 4-demethoxy-daunorubicin. Invest New Drugs 1: 161","journal-title":"Invest New Drugs"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method of quantitation of microgram quantities of protein utilising the principle of protein dye binding. Anal Biochem 72: 248","journal-title":"Anal Biochem"},{"key":"CR5","first-page":"6608","volume":"50","author":"GR Braslawsky","year":"1990","unstructured":"Braslawsky GR, Edson MA, Pearce W, Kaneko T, Greenfield RS (1990) Antitumor activity of adriamycin (hydrazone-linked) immunoconjugates compared with free adriamycin and specificity of tumor cell killing. Cancer Res 50: 6608","journal-title":"Cancer Res"},{"key":"CR6","first-page":"6883","volume":"50","author":"DC Case Jr","year":"1990","unstructured":"Case DC Jr, Hayes DM, Gerber M, Gams R, Ervin TJ, Dorsk BM (1990) Phase II study of oral idarubicin in favorable histology non-Hodgkins lymphoma. Cancer Res 50: 6883","journal-title":"Cancer Res"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0145-2126(88)90073-2","volume":"12","author":"MA Rie De","year":"1988","unstructured":"De Rie MA, Zeijlemaker WP, and von dem Borne AE (1988) Inhibition by vinca alkaloids and colchicine of antigenic modulation induced by anti-CD19 monoclonal antibodies. Leukemia Res 12: 135","journal-title":"Leukemia Res"},{"key":"CR8","first-page":"257","volume-title":"Cancer; principles and practice of oncology","author":"VT DeVita","year":"1985","unstructured":"DeVita VT (1985) Principles of chemotherapy. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer; principles and practice of oncology. Lippincott, Philadelphia, pp 257?284"},{"key":"CR9","first-page":"1","volume":"3","author":"RO Dillman","year":"1990","unstructured":"Dillman RO (1990) Human antimouse and antiglobulin responses to monoclonal antibodies. Antibody Immunoconjugates and Radiopharmaceuticals 3: 1","journal-title":"Antibody Immunoconjugates and Radiopharmaceuticals"},{"key":"CR10","first-page":"4886","volume":"46","author":"RO Dillman","year":"1986","unstructured":"Dillman RO, Shawler DL, Johnson DE, Meyer DL, Koziol JA, Frincke JM (1986) Comparative preclinical trials with combinations and conjugates of T101 and doxorubicin. Cancer Res 46: 4886","journal-title":"Cancer Res"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0161-5890(78)90070-6","volume":"15","author":"PL Ey","year":"1978","unstructured":"Ey PL, Prowse SJ, Jenkin CR (1978) Isolation of pure IgG1, IgG2 a and IgG2b immunoglobulins from mouse serum using protein A Sepharose. Immunochemistry 15: 429","journal-title":"Immunochemistry"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J","volume":"18","author":"GE Foley","year":"1965","unstructured":"Foley GE, Lazarus H, Farber S, Uzman BG, Boone BA, McCarthy RE (1965) Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 18: 522","journal-title":"Cancer"},{"key":"CR13","first-page":"2610","volume":"48","author":"MA Ghetie","year":"1988","unstructured":"Ghetie MA, May RD, Till M, Uhr JW, Ghetie V, Knowles PP, Relf M, Brown A, Wallace PM, Janossy G, Amlot P, Vitetta ES, Thorpe PE (1988) Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy. Cancer Res 48: 2610","journal-title":"Cancer Res"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1182\/blood.V79.3.576.576","volume":"79","author":"ML Grossbard","year":"1992","unstructured":"Grossbard ML, Freedman AS, Ritz J, Coral F, Goldmacher VS, Eliseo L, Spector N, Dear K, Lambert JM, Blattler WA, Taylor JA, Nadler LM (1992) Serotherapy of B-cell neoplasms with anti-B4-blocked-ricin-a: phase I trial of daily bolus infusion. Blood 79: 576","journal-title":"Blood"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"7898","DOI":"10.1073\/pnas.83.20.7898","volume":"83","author":"Y Haruta","year":"1986","unstructured":"Haruta Y, Seon BK (1986) Distinct human leukemia-associated cell surface glycoprotein GP160 defined by monoclonal antibody SN6. Proc Natl Acad Sci USA 83: 7898","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/BF01741331","volume":"32","author":"A Hekman","year":"1991","unstructured":"Hekman A, Honselaar A, Vuist WMJ, Sein JJ, Rodenhuis S, ten Bokkel-Huinink WW, Somers R, Rumke PH, Melief CJ (1991) Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibody. Cancer Immunol Immunother 32: 364","journal-title":"Cancer Immunol Immunother"},{"key":"CR17","first-page":"165","volume-title":"Monoclonal antibodies and cancer therapy","author":"D Herlyn","year":"1985","unstructured":"Herlyn D, Lubeck M, Steplewski Z, Kowprowski H (1985) Destruction of human tumors by IgG2 a monoclonal antibodies and macrophages. In: Reisfeld RA, Sell S (eds) Monoclonal antibodies and cancer therapy. Alan R. Liss, New York, pp 165?172"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1200\/JCO.1989.7.12.1932","volume":"1","author":"AA Hertler","year":"1989","unstructured":"Hertler AA, Frankel AE (1989) Immunotoxins: a clinical review of their use in the treatment of malignancies. J Clin Oncol 1: 1932","journal-title":"J Clin Oncol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00175378","volume":"2","author":"S Kaplan","year":"1984","unstructured":"Kaplan S, Sessa C, Willems Y, Pacciarini MA, Tamassia V, Cavalli F (1984) Phase I trial of 4-demethoxydaunorubicin (idarubicin) with single oral doses. Invest New Drugs 2: 281","journal-title":"Invest New Drugs"},{"key":"CR20","first-page":"6236","volume":"51","author":"JM Lambert","year":"1991","unstructured":"Lambert JM, Goldmacher VS, Collinson AR, Nadler LM, Blattler WA (1991) An immunotoxin prepared with blocked ricin: a natural plant toxin adapted for therapeutic use. Cancer Res 51: 6236","journal-title":"Cancer Res"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1182\/blood.V65.6.1349.bloodjournal6561349","volume":"65","author":"TC Meeker","year":"1985","unstructured":"Meeker TC, Lowder J, Maloney DG, Miller RA, Thielemans K, Warnke R, Levy R (1985) A clinical trial of anti-idotype therapy for B cell malignancy. Blood 65: 1349","journal-title":"Blood"},{"key":"CR22","first-page":"302","volume-title":"Leukocyte typing III","author":"AJ McMichael","year":"1987","unstructured":"McMichael AJ (1987) Leukocyte typing III. Oxford University Press, Oxford, pp 302?363, 432?469"},{"key":"CR23","first-page":"926","volume":"48","author":"GA Pietersz","year":"1988","unstructured":"Pietersz GA, Smyth MJ, McKenzie IFC (1988) Immunochemotherapy of a murine thymoma with the use of idarubicin monoclonal antibody conjugates. Cancer Res 48: 926","journal-title":"Cancer Res"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-065X.1992.tb01419.x","volume":"129","author":"GA Pietersz","year":"1992","unstructured":"Pietersz GA and McKenzie IFC (1992) Antibody conjugates for the treatment of cancer. Immunological Reviews 129: 57","journal-title":"Immunological Reviews"},{"key":"CR25","first-page":"189","volume":"5","author":"MV Pimm","year":"1988","unstructured":"Pimm MV (1988) Drug-monoclonal antibody conjugates for cancer therapy: potentials and limitations. CRC Crit Rev Ther Drug Carrier Syst 5: 189","journal-title":"CRC Crit Rev Ther Drug Carrier Syst"},{"key":"CR26","first-page":"4906","volume":"49","author":"OW Press","year":"1981","unstructured":"Press OW, Farr AG, Borroz I, Anderson SK, Martin PJ (1981) Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies. Cancer Res 49: 4906","journal-title":"Cancer Res"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1182\/blood.V69.2.584.584","volume":"69","author":"OW Press","year":"1987","unstructured":"Press OW, Appelbaum F, Ledbetter JA, Martin PJ, Zarling J, Kidd P, Thomas ED (1987) Monoclonal antibody IF5 (Anti-CD20) serotherapy of human B cell lymphomas. Blood 69: 584","journal-title":"Blood"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1200\/JCO.1989.7.8.1027","volume":"7","author":"OW Press","year":"1989","unstructured":"Press OW, Eary J, Badger C, Martin PJ, Appelbaum F, Levy R, Miller R, Brown S, Nelp WB, Krohn KA, Fisher D, De Santes K, Porter B, Kidd P, Thomas ED, Bernstein ID (1989) Treatment of refractory non-Hodgkin's lymphoma with radiolabelled MB-1 (anti-CD37) antibody. J Clin Oncol 7: 1027","journal-title":"J Clin Oncol"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1182\/blood.V65.6.1373.bloodjournal6561373","volume":"65","author":"EM Rankin","year":"1985","unstructured":"Rankin EM, Hekman A, Somers R, ten Bokkel-Huinink W (1985) Treatment of two patients with B cell lymphoma with monoclonal anti-idiotype antibodies. Blood 65: 1373","journal-title":"Blood"},{"key":"CR30","first-page":"503","volume":"76","author":"MJ Smyth","year":"1986","unstructured":"Smyth MJ, Pietersz GA, Classon BJ, McKenzie IFC (1986) Specific targeting of chlorambucil to tumors with the use of monoclonal antibodies. JNCI 76: 503","journal-title":"JNCI"},{"key":"CR31","first-page":"310","volume":"51","author":"MJ Smyth","year":"1991","unstructured":"Smyth MJ, Bogdanovski M, McKenzie IFC, Pietersz GA (1991) Antitumor activity of idarubicin-monoclonal antibody conjugates in a disseminated thymic lymphoma model. Cancer Res 51: 310","journal-title":"Cancer Res"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0192-0561(92)90041-I","volume":"14","author":"AM Sole-Rodriguez","year":"1992","unstructured":"Sole-Rodriguez AM, Uhr JW, Richardson J, Vitetta ES (1992) The toxicity of chemically deglycosylated ricin A-chain in mice. Int J Immunopharmacol 14: 281","journal-title":"Int J Immunopharmacol"},{"key":"CR33","first-page":"377","volume":"52","author":"C Sung","year":"1992","unstructured":"Sung C, Shockley TR, Morrison PF, Dvorak HF, Yarmush ML, Dedrick RL (1992) Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors. Cancer Res 52: 377","journal-title":"Cancer Res"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0022-1759(88)90088-9","volume":"110","author":"J-G Teh","year":"1987","unstructured":"Teh J-G, Thompson CH, McKenzie IFC (1987) Production of monoclonal antibodies to serum antigens in colorectal carcinoma. J Immunol Methods 110: 101","journal-title":"J Immunol Methods"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1432-1033.1985.tb08737.x","volume":"147","author":"PE Thorpe","year":"1985","unstructured":"Thorpe PE, Detre SI, Foxwell BMJ, Brown ANF, Skilleter DN, Wilson G, Forrester JA, Stirpe F (1985) Modification of the carbohydrate in ricin with metaperiodate-cyanoborohydride mixtures. Effects on toxicity and in vivo distribution. Eur J Biochem 147: 197","journal-title":"Eur J Biochem"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood.V71.1.13.13","volume":"71","author":"FM Uckun","year":"1988","unstructured":"Uckun FM, Jaszcz W, Ambrus JL, Fauci AS, Gajl-Peczalska K, Song CW, Wick MR, Myers DE, Waddick K, Ledbetter JA (1988) Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti-CD19 immunotoxins. Blood 71: 13","journal-title":"Blood"},{"key":"CR37","first-page":"4052","volume":"51","author":"ES Vitetta","year":"1991","unstructured":"Vitetta ES, Stone M, Amlot P, Fay J, May R, Till M, Newman J, Clark P, Collins R, Cunningham D, Ghetie B, Uhr JW, Thorpe PE (1991) Phase I immunotoxin trial in patients with B-cell lymphoma. Cancer Res 51: 4052","journal-title":"Cancer Res"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0167-5699(87)90018-1","volume":"8","author":"H Zola","year":"1987","unstructured":"Zola H (1987) The surface antigens of human B lymphocytes. Immunol Today 8: 308","journal-title":"Immunol Today"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/icb.1991.58","volume":"69","author":"H Zola","year":"1991","unstructured":"Zola H, MacArdle PJ, Bradford T, Weedon H, Yasui H, Kurosawa Y (1991) Preparation and characterization of a chimeric CD19 monoclonal antibody. Immunol Cell Biol 69: 411","journal-title":"Immunol Cell Biol"}],"container-title":["Cancer Immunology Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01525435\/fulltext.html","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01525435.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01525435\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01525435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:03:31Z","timestamp":1586217811000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01525435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,5]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1993,5]]}},"alternative-id":["BF01525435"],"URL":"https:\/\/doi.org\/10.1007\/bf01525435","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,5]]}}}